Bapineuzumab (Anti-Amyloid Beta) Beta Amyloid antibody | Read Reviews & Product Use Citations

Bapineuzumab (Anti-Amyloid Beta) is a monoclonal antibody targeting β-amyloid protein (APP). It can be used for the research of Alzheimer’s disease (AD). MW :140.16 KD.

Purity & Quality Control

Batch: A311101 Purity: 99% Protein concentration: 4.81mg/ml Endotoxin Level: ＜1EU/mg

99

Choose Selective Beta Amyloid Inhibitors

Name	Citation	Beta Amyloid	Others
DAPT	365	+++	Notch
RO4929097	115	+++	γ secretase,Notch
Semagacestat (LY450139)	20	+++	Notch
MK-0752	23	++++
Avagacestat (BMS-708163)	22	++++
LY2811376	19	++	BACE1
CRANAD-2	0	++
Hoechst 34580	1	+
Frentizole	0	+
Simufilam	✔
Ginsenoside Rg1	✔	NF-κB
Ginsenoside Re	✔	NF-κB,JNK
Tabersonine hydrochloride	✔
EUK 134	✔

Expand to Check More

1. "+" indicates inhibitory effect. Increased inhibition is marked by a higher "+" designation. 2. "✔" indicates inhibitory effect, but without specific value.

Biological Activity

Description	Bapineuzumab (Anti-Amyloid Beta) is a monoclonal antibody targeting β-amyloid protein (APP). It can be used for the research of Alzheimer’s disease (AD). MW :140.16 KD.

References
[1] Salloway S, et al. N Engl J Med. 2014 Jan 23;370(4):322-33.

References

[1] Salloway S, et al. N Engl J Med. 2014 Jan 23;370(4):322-33.

Product Details

CAS No.	648895-38-9
Isotype	Human IgG1
Source	CHO
Formulation	100mMPro-Ac,20mMArg-Ac，pH5.0
Storage (From the date of receipt)	Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field